- Home
- G vs ICLR Comparison
G vs ICLR Comparison
Compare G & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | G | ICLR |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | Bermuda | Ireland |
| Employees | 140000 | N/A |
| Industry | Professional Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 7.1B |
| IPO Year | 2007 | 2001 |
Fundamental Metrics
Financial Performance| Metric | G | ICLR |
|---|---|---|
| Price | $36.81 | $102.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $49.50 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 1.8M | 913.1K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 9.82 | N/A |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $2,279,438,000.00 | N/A |
| Revenue This Year | $9.23 | N/A |
| Revenue Next Year | $7.26 | N/A |
| P/E Ratio | ★ $11.96 | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.79 | $66.57 |
| 52 Week High | $50.71 | $211.00 |
Technical Indicators
Market Signals| Indicator | G | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 35.27 | 41.85 |
| Support Level | $34.79 | $95.75 |
| Resistance Level | $46.04 | $113.88 |
| Average True Range (ATR) | 1.07 | 4.14 |
| MACD | -0.07 | 2.18 |
| Stochastic Oscillator | 22.17 | 52.02 |
Price Performance
Historical ComparisonAbout G Genpact Limited
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.